Lessee, Operating Lease, Liability, to be Paid, Year Three in USD of Galera Therapeutics, Inc. from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Galera Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and change rate from Q4 2018 to Q2 2024.
  • Galera Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Jun 2024 was $224K, a 1.82% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

Galera Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $224K +$4K +1.82% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $224K 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $220K 31 Dec 2023 10-K 28 Mar 2024
Q3 2023 $220K 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $220K 30 Jun 2023 10-Q 14 Aug 2023
Q4 2020 $44K -$216K -83.1% 31 Dec 2020 10-K 11 Mar 2021
Q3 2020 $44K -$220K -83.3% 30 Sep 2020 10-Q 10 Nov 2020
Q2 2020 $260K 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $260K 31 Mar 2020 10-Q 12 May 2020
Q4 2019 $260K -$132K -33.7% 31 Dec 2019 10-K 10 Mar 2020
Q3 2019 $264K 30 Sep 2019 10-Q 10 Dec 2019
Q4 2018 $392K 31 Dec 2018 10-Q 10 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.